Companies · Other Health Care

Scanadu Inc

SUNNYVALE · Other Health Care

Diligence memoA one-page analyst read on Scanadu Inc — recommendation, valuation, rhythm, risks.
$44.7M
Total raised · real
3
Rounds
0.5×
Latest step-up
Top 10%
Sector rank · raised
Series B
Latest stage · inferred · Mon May 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time)

Scanadu Inc looks under-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.16× the median modeled value of Series B Other Health Care companies in 2016–2018 (74 peers) — value vs value, same stage and era.
Dormant
  • Last raise 8.1 yr ago; this sector typically re-raises about every 14 months.
  • Silent for over 3× the sector's normal cadence.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Scanadu Inc is one of 5377 Other Health Care companies tracked from SUNNYVALE. By capital raised it ranks among the largest (ahead of 91% of sector peers), and in the upper tier by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
28
Investors (latest)
2018-05-21
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$250M$500M$750M$1.0BSeries B · 2014-07-10 Raised $35M (real) Modeled valuation $775M (est)$35M$775MSeries B2014Series B · 2016-06-13 Raised $6.5M (real) Modeled valuation $144M (est)$6.5M$144MSeries B2016Series B · 2018-05-21 Raised $3.2M (real) Modeled valuation $72M (est)$3.2M$72MSeries B2018+$6.5M+$3.2MCumulative $45M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series B$35.0M · 2014
Series B extension$6.5M · 2016
Series B extension$3.2M · 2018

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed, Series A — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 25%.

Modeled valuation trajectory
$71.9M
Base estimate est.
$7.6M
Conservative case
$276.6M
Upside case
$18.0M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Ba $15M–$40M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Series B · modeled $775.4M · 2014-07-102014Series B · modeled $144.0M · 2016-06-13Series B · modeled $71.9M · 2018-05-212018
Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
64%
Survival probability
42% low · 78% high
1.36×/yr
Annual markup
1.64×/yr upside case
6.0 yr
Elapsed time used
8.1 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
23 mo
Avg between rounds
$11.6M/yr
Capital velocity
12.0 yr
On record since
2014
First round
3
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 18× above median
This company$44.7M
Sector median$2.4M
Latest round — vs other Series B rounds in sector (real $, this stage) 0.2× of median
This company$3.2M
Sector median$17.8M
Modeled value — vs sector median (estimate, all stages) 3.3× above median
This company$71.9M
Sector median$22.1M

Raised more than 91% of sector peers (real $). Modeled value above 73% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series B) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #67 of 74.

This companyCohort peer
$10.0M$100.0M$1.0B$10.0B$10.0M$100.0M$1.0BCapital raised (log)Podicare Services, Inc. · Series B Raised $40.0M · modeled $886.2M (est)COTA, Inc. · Series B Raised $43.8M · modeled $886.2M (est)Fresenius Medical Care - Meridian Health System, LLC · Series B Raised $39.0M · modeled $863.9M (est)Headspace, Inc. · Series B Raised $115.9M · modeled $860.6M (est)Spine Holdings LLC · Series B Raised $38.4M · modeled $851.6M (est)Chrono Therapeutics Inc. · Series B Raised $51.4M · modeled $833.2M (est)MedCPU, Inc. · Series B Raised $36.6M · modeled $776.2M (est)Capital Funding Bancorp, Inc. · Series B Raised $35.0M · modeled $775.4M (est)Phreesia, Inc. · Series B Raised $83.8M · modeled $753.2M (est)Labconnect Holdings, Inc. · Series B Raised $33.4M · modeled $739.0M (est)Zoonie, LLC · Series B Raised $52.0M · modeled $708.1M (est)Sotera Wireless, Inc. · Series B Raised $98.5M · modeled $705.3M (est)Scanadu Inc (this company) Raised $44.7M · modeled $71.9M (est)Scanadu Inc
CompanyStageRaised · realValue · estvs peer med.
Podicare Services, Inc.Series B$40.0M$886.2M1.98×
COTA, Inc.Series B$43.8M$886.2M1.98×
Fresenius Medical Care - Meridian Health System, LLCSeries B$39.0M$863.9M1.93×
Headspace, Inc.Series B$115.9M$860.6M1.92×
Spine Holdings LLCSeries B$38.4M$851.6M1.90×
Chrono Therapeutics Inc.Series B$51.4M$833.2M1.86×
MedCPU, Inc.Series B$36.6M$776.2M1.73×
Capital Funding Bancorp, Inc.Series B$35.0M$775.4M1.73×
Phreesia, Inc.Series B$83.8M$753.2M1.68×
Labconnect Holdings, Inc.Series B$33.4M$739.0M1.65×
Zoonie, LLCSeries B$52.0M$708.1M1.58×
Sotera Wireless, Inc.Series B$98.5M$705.3M1.58×
Scanadu Inc this companySeries B$44.7M$71.9M0.16×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series B$35.0M2014-07-10$194.4M$775.4M85%
Series B$6.5M2016-06-13$36.1M$144.0M90%
Series B$3.2M2018-05-21$18.0M$71.9M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series B$35.0M2014-07-10
    • First recorded raise — entered as Series B.
    • 15 investors on this round.
  2. Series B$6.5M2016-06-13
    • Raised again after 23 mo — slower than the ~14 mo sector norm.
    • Round 5.4× smaller than the prior — bridge or down round.
    • 8 investors on this round.
  3. Series B$3.2M2018-05-21
    • Raised again after 23 mo — slower than the ~14 mo sector norm.
    • Round 2.0× smaller than the prior — bridge or down round.
    • 28 investors on this round.
Intelligence
2020 ~Q2
Modeled next raise · ~23mo cadence
$3.2M
Modeled next size est.range $3.2M$5.2M
0.5×
Last step-up
$11.6M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
David King15 other2016-06
Kevin Talbot8 other2014-07
Gerard Van Hamel Platerink5 other2016-06
Robert Harrington2 other2014-07
Scott Bonham1 other2014-07
Walter De Brouwer1 other2014-07
Bob Gardner2014-07
Daya Ranamukhaarachchi2014-07
Ezra Kucharz2014-07
Jackie Schneider2014-07
Jaime Tenedorio2016-06
Jamie Tenedorio2014-07
Reza Kazemipour2018-05
Sam De Brouwer2014-07
Sriram Vaidyanathan2018-05
Registry & provenance

Scanadu Inc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1612399
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
SignalPath, LLCOther Health CareSeries B$34.1M$402.8Mnetwork1 shared operator · same sector · same stage
Augmedix, Inc.Other Health CareSeries B$67.9M$113.2Mnetwork1 shared operator · same sector · same stage
Wavetec Vision Systems IncOther Health CareSeries B$99.9M$64.1Mnetwork1 shared operator · same sector · same stage
AVAVA, Inc.Other Health CareSeries B$48.8M$78.0Msame sector · same stage
MedArrive Inc.Other Health CareSeries B$40.8M$76.7Msame sector · same stage
Iscience Interventional CorpOther Health CareSeries B$40.3M$61.1Msame sector · same stage
MediView XR, Inc.Other Health CareSeries B$39.4M$78.6Msame sector · same stage
Colorescience IncOther Health CareSeries B$51.2M$66.5Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Scanslated, Inc.Other Health CarePre-Seed$2.7M87%
DIGOSTICS LtdOther Health CarePre-Seed$5.3M84%
Aptus Inc.Other Health CareSeed$38.8M84%
Dentulu IncOther Health CareSeed$37.7M83%
MedArrive Inc.Other Health CareSeries B$76.7M83%
SedMed Inc.Other Health CareSeed$6.1M82%
Hippaware, Inc.Other Health CarePre-Seed$1.2M82%
Genomedx Inc.Other Health CareSeries B$176.3M82%
Frequently asked
How much funding has Scanadu Inc raised?
Scanadu Inc has raised approximately $44.7M in disclosed capital across 3 recorded financing rounds, aggregated from public filings.
What is Scanadu Inc's estimated valuation?
Provath's modeled valuation for Scanadu Inc is approximately $71.9M (modeled range $7.6M–$276.6M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Scanadu Inc at?
Scanadu Inc's latest modeled financing stage is Series B. Its most recent recorded round closed around Mon May 21.
What does Scanadu Inc do and where is it based?
Scanadu Inc operates in the Other Health Care sector, based in SUNNYVALE.
Explore related

See where Scanadu Inc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Scanadu Inc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.